The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma

Hanno Witte; Harald Biersack; Svenja Kopelke; Dirk Rades; Hartmut Merz; Veronica Bernard; Hendrik Lehnert; Sebastian Fetscher; Niklas Gebauer

doi:10.1111/bjh.15198

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma

Hanno Witte, Harald Biersack, Svenja Kopelke, Dirk Rades, Hartmut Merz, Veronica Bernard, Hendrik Lehnert, Sebastian Fetscher, Niklas Gebauer

9 Zitate (Scopus)

Abstract

Positron emission tomography (PET)‐guided strategies emerge as standard‐of‐care for advanced‐stage classical Hodgkin lymphoma (cHL) while conflict remains regarding early stage (I – IIa) disease and the necessity for treatment‐intensification among patients with a positive PET after two chemotherapy cycles (PET‐2) (Borchmann et al, 2017). Risk‐stratification remains crucial, increasing the requirement for predictive biomarkers.

...

Originalsprache	Englisch
Zeitschrift	British Journal of Haematology
Jahrgang	184
Ausgabenummer	5
Seiten (von - bis)	869-873
Seitenumfang	5
ISSN	0007-1048
DOIs	https://doi.org/10.1111/bjh.15198
Publikationsstatus	Veröffentlicht - 01.03.2019

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Profilbereich: Lübeck Integrated Oncology Network (LION)

Dokumente

10.1111/bjh.15198

Weitere Links

Zitieren

@article{f8ff701b2ff34bb9b79fc8d9bac58ab8,

title = "The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma",

abstract = "Positron emission tomography (PET)‐guided strategies emerge as standard‐of‐care for advanced‐stage classical Hodgkin lymphoma (cHL) while conflict remains regarding early stage (I – IIa) disease and the necessity for treatment‐intensification among patients with a positive PET after two chemotherapy cycles (PET‐2) (Borchmann et al, 2017). Risk‐stratification remains crucial, increasing the requirement for predictive biomarkers. ...",

author = "Hanno Witte and Harald Biersack and Svenja Kopelke and Dirk Rades and Hartmut Merz and Veronica Bernard and Hendrik Lehnert and Sebastian Fetscher and Niklas Gebauer",

year = "2019",

month = mar,

day = "1",

doi = "10.1111/bjh.15198",

language = "English",

volume = "184",

pages = "869--873",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma

AU - Witte, Hanno

AU - Biersack, Harald

AU - Kopelke, Svenja

AU - Rades, Dirk

AU - Merz, Hartmut

AU - Bernard, Veronica

AU - Lehnert, Hendrik

AU - Fetscher, Sebastian

AU - Gebauer, Niklas

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Positron emission tomography (PET)‐guided strategies emerge as standard‐of‐care for advanced‐stage classical Hodgkin lymphoma (cHL) while conflict remains regarding early stage (I – IIa) disease and the necessity for treatment‐intensification among patients with a positive PET after two chemotherapy cycles (PET‐2) (Borchmann et al, 2017). Risk‐stratification remains crucial, increasing the requirement for predictive biomarkers. ...

AB - Positron emission tomography (PET)‐guided strategies emerge as standard‐of‐care for advanced‐stage classical Hodgkin lymphoma (cHL) while conflict remains regarding early stage (I – IIa) disease and the necessity for treatment‐intensification among patients with a positive PET after two chemotherapy cycles (PET‐2) (Borchmann et al, 2017). Risk‐stratification remains crucial, increasing the requirement for predictive biomarkers. ...

UR - https://www.scopus.com/pages/publications/85047500783

UR - http://www.mendeley.com/research/glasgow-prognostic-score-diagnosis-independent-predictor-survival-advanced-stage-classical-hodgkin-l

U2 - 10.1111/bjh.15198

DO - 10.1111/bjh.15198

M3 - Journal articles

C2 - 29785776

AN - SCOPUS:85047500783

SN - 0007-1048

VL - 184

SP - 869

EP - 873

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 5

ER -

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma

Abstract

UN SDGs

Strategische Forschungsbereiche und Zentren

Dokumente

Weitere Links

Fingerprint

Zitieren